Glaucoma is an eye disease that causes loss of vision and damage to the optic nerve. Open-angle glaucoma, also known as wide-angle glaucoma, is the most common type of glaucoma in the world. Glaucoma is characterized by increased intraocular pressure, which causes damage to the optic nerve.
This report contains market size and forecasts of Open Angle Glaucoma Drugs in global, including the following market information:
Global Open Angle Glaucoma Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Open Angle Glaucoma Drugs Market Sales, 2017-2022, 2023-2028, (K Bottles)
Global top five Open Angle Glaucoma Drugs companies in 2021 (%)
The global Open Angle Glaucoma Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prostaglandins Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Open Angle Glaucoma Drugs include Merck, Allergan, Pfizer, Novartis, Bausch Health and Santen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Open Angle Glaucoma Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Open Angle Glaucoma Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Bottles)
Global Open Angle Glaucoma Drugs Market Segment Percentages, by Type, 2021 (%)
Prostaglandins
Carbonic Anhydrase Inhibitor
Cholinergic Drugs
Others
Global Open Angle Glaucoma Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Bottles)
Global Open Angle Glaucoma Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Global Open Angle Glaucoma Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Bottles)
Global Open Angle Glaucoma Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Open Angle Glaucoma Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Open Angle Glaucoma Drugs revenues share in global market, 2021 (%)
Key companies Open Angle Glaucoma Drugs sales in global market, 2017-2022 (Estimated), (K Bottles)
Key companies Open Angle Glaucoma Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Allergan
Pfizer
Novartis
Bausch Health
Santen